Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Total 13F shares
-
514,772,354
-
Share change
-
-38,233,520
-
Total reported value
-
$5,801,411,223
-
Put/Call ratio
-
10%
-
Price per share
-
$11.27
-
Number of holders
-
337
-
Value change
-
-$418,510,063
-
Number of buys
-
178
-
Number of sells
-
143
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q2 2025
As of 30 Jun 2025 Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) had 337 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 514,772,354 shares of stock of the company.
Largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, FMR LLC, MORGAN STANLEY, BlackRock, Inc., VANGUARD GROUP INC, VIKING GLOBAL INVESTORS LP, QVT Financial LP, Rubric Capital Management LP, STATE STREET CORP, and Patient Square Capital LP.
This table shows 338 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.